Pediatrics International · 2013 · 23 citations · 9 references
Life SciencesImmunologyPediatricsAllergyHypersensitivityPediatric AllergyAnaphylaxisDrug AllergyHypersensitivity PharmacologyHypersensitivity Reaction ManagementAcute Lymphoblastic Leukemia TreatmentAnaphylaxis Clinical PresentationAnaphylaxis In ChildrenAnaphylaxis TreatmentAsparaginase Hypersensitivity ManagementAsparaginase TherapyPediatric AnaphylaxisPolyethylene Glycol Conjugation
In hypersensitive reactions to native L-asparaginase, either premedication and desensitization or substitution with polyethylene glycol conjugated asparaginase (PEG-ASP) is preferred. Anaphylaxis with PEG-ASP is rare. An 8-year-old girl and a 2.5-year-old boy, both diagnosed as having acute lymphoblastic leukemia, presented with native L-asparaginase hypersensitivity and substitution with PEG-ASP was preferred. They received a premedication (methylprednisolone, hydroxyzine and ranitidine) followed by desensitization with PEG-ASP infusion. Both patients developed anaphylaxis with peg-asparaginase. These are the first reported cases of anaphylactic reaction to PEG-ASP, despite the application of both premedication and desensitization. Anaphylaxis with PEG-ASP is very rare and premedication and desensitization protocols may not prevent these hypersensitive reactions.
9
E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children
Lisa Tallal, Charlotte Tan, Herbert F. Oettgen et al. · Cancer · 1970 · 175 citations
Medicine, Pediatrics, Pharmacology +15